The interaction of Ephexin1 with Axin1 affected β-catenin stability and Wnt signaling, indicating that Ephexin1 could be a valuable target for enhancing the efficacy of Wnt pathway inhibitors in CRC treatment. Here, AXIN1 is linked to colorectal carcinoma.